Literature DB >> 10813293

Longterm outcome of Wegener's granulomatosis in patients with renal disease requiring dialysis.

T M Mekhail1, G S Hoffman.   

Abstract

OBJECTIVE: It is known that renal failure is a poor prognostic marker for survival in Wegener's granulomatosis (WG). We investigated the longterm outcome of patients with WG who have severe renal disease requiring dialysis.
METHODS: We performed a retrospective analysis of 104 patients with WG followed at our institution between 1982 and 1997. Twenty-three patients who required dialysis were studied in detail to determine outcomes and factors that influenced survival and restoration of renal function.
RESULTS: Of 23 dialysis dependent patients with WG, 11 died (Group 1). 7 either remained dialysis dependent or received successful renal transplants (Group 2), and 5 substantially recovered renal function (Group 3). Mean serum creatinine at the end of a mean followup period of 38.4 months for Group 3 was 1.8 mg/dl. There was no apparent difference between groups in regard to disease profile, e.g., distribution of organ involvement or serum creatinine when renal impairment was first recognized (mean serum creatinine for groups: 1: 3.0 mg/dl; 2: 5.6 mg/dl; 3: 5.5 mg/dl) and peak serum creatinine prior to dialysis (means for groups: 1: 9.5 mg/dl; 2: 10.5 mg/dl; 3: 9.6 mg/dl). Infection secondary to immunosuppression was the leading cause of death in Group I patients.
CONCLUSION: Because the clinical profile and degree of renal failure, as judged by serum creatinine, did not differ among patients who did or did not regain dialysis independent renal function, we recommend aggressive immunosuppressive therapy in all cases of active WG with acute rapidly worsening renal failure, regardless of the severity of renal impairment.

Entities:  

Mesh:

Year:  2000        PMID: 10813293

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Wegener's granulomatosis presenting as a pleural effusion.

Authors:  Adrian G Blundell; Simon Roe
Journal:  BMJ       Date:  2003-07-12

2.  Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey.

Authors:  Zeynep Ozbalkan; Sedat Kiraz; M Akif Ozturk; A Ihsan Ertenli; Sule Apras; Meral Calguneri
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

3.  Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.

Authors:  Duvuru Geetha; Caroline J Poulton; Yichun Hu; Philip Seo; Julie Anne G McGregor; Ronald J Falk; Susan L Hogan
Journal:  Semin Arthritis Rheum       Date:  2013-12-04       Impact factor: 5.532

Review 4.  [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

Authors:  Jan Henrik Schirmer; Peer M Aries; Kirsten de Groot; Bernhard Hellmich; Julia U Holle; Christian Kneitz; Ina Kötter; Peter Lamprecht; Ulf Müller-Ladner; Eva Reinhold-Keller; Christof Specker; Michael Zänker; Frank Moosig
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

5.  Rituximab for treatment of severe renal disease in ANCA associated vasculitis.

Authors:  Duvuru Geetha; Zdenka Hruskova; Marten Segelmark; Jonathan Hogan; Matthew D Morgan; Teresa Cavero; Per Eriksson; Philip Seo; Rebecca L Manno; Jessica Dale; Lorraine Harper; Vladimir Tesar; David Rw Jayne
Journal:  J Nephrol       Date:  2015-05-19       Impact factor: 3.902

Review 6.  Management of acute renal failure in the elderly patient: a clinician's guide.

Authors:  Ching M Cheung; Arvind Ponnusamy; John G Anderton
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States.

Authors:  Amanda M Kong; Gilwan Kim; Margaret Michalska; Jennie H Best
Journal:  Rheumatol Ther       Date:  2018-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.